To test this hypothesis, we transiently transfected BRAFi-sensitive and BRAFi-R2 melanoma cells with two independent IL-6-targeting siRNA oligonucleotides to reduce IL-6 secretion and signaling (Figure 4A,B). This evidence concerns the gene IL6 and melanoma.